The RUNX1 Research Program awards grants through two programs with our partners Alex's Lemonade Stand Foundation and the Leukemia and Lymphoma Society.
RUNX1-LLS (Leukemia and Lymphoma Society) Program
The RUNX1 Research Program has partnered with The Leukemia and Lymphoma Society (LLS) to provide grants of $200,000 per year for three years for translational leukemia research related to the germline RUNX1 disorder. 2017 RUNX1-LLS grant awardees have now been named. Learn more about the recipients and their proposed investigation.
The RUNX1 Research Program/LLS Grant Program for 2018 will be announced in September 2017 as part of the LLS TRP announcements.
RUNX1-ALSF (Alex's Lemonade Stand Foundation) Program
The RUNX1 Research Program has partnered with Alex's Lemonade Stand for Childhood Cancer to fund new and innovative research into therapeutics that would prevent the transition from the disorder to leukemia.
Awards are for $125,000 per year for two years for research leading to the prevention of the transition from pre-leukemia to leukemia for patients with the familial RUNX1 disorder. 2016 grants have been awarded. Learn more about the recipients and their research.